Skip to main content
Premium Trial:

Request an Annual Quote

Singlera Genomics Closes $150M Series B Financing Round

NEW YORK — Singlera Genomics said on Tuesday that it has raised $150 million in a Series B financing round.

The round was led by CICC Kai Tak Innovative Biomedicine Fund and co-led by Detong Capital and Furong Investment. New investors include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, and Shanghai Free Trade Zone Fund. Existing investors participating in the financing include Greenpine Capital, Prosperico Ventures, and Proxima Ventures.

Singlera said it will use the new funding to expand its research and development of new early cancer screening products, to support regulatory and commercialization activities, and to expand prospective studies into pan-cancer early screening.

This summer, Singlera and collaborators at Fudan University published data showing that the company's circulating tumor DNA methylation multi-cancer screening technology, called PanSeer, could help detect cancer in asymptomatic people who were later diagnosed with cancer.

While La Jolla, California-based Singlera, which also has operations in Shanghai, is initially focusing on colorectal cancer detection with the PanSeer technology, it aims to expand to a pan-cancer setting in the future.

"We have developed early cancer screening and diagnostic technologies and products covering a variety of cancer types including lung, colorectal, liver, stomach, esophageal, pancreatic, and thyroid," Singlera Cofounder and scientific advisor Yuan Gao said in a statement. "This round of financing will help us carry out large-scale prospective studies and clinical trials."

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.